JP2023516010A5 - - Google Patents
Info
- Publication number
- JP2023516010A5 JP2023516010A5 JP2022551783A JP2022551783A JP2023516010A5 JP 2023516010 A5 JP2023516010 A5 JP 2023516010A5 JP 2022551783 A JP2022551783 A JP 2022551783A JP 2022551783 A JP2022551783 A JP 2022551783A JP 2023516010 A5 JP2023516010 A5 JP 2023516010A5
- Authority
- JP
- Japan
- Prior art keywords
- payload
- protein
- nucleic acid
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981464P | 2020-02-25 | 2020-02-25 | |
| US62/981,464 | 2020-02-25 | ||
| US202063079841P | 2020-09-17 | 2020-09-17 | |
| US63/079,841 | 2020-09-17 | ||
| PCT/CA2021/050236 WO2021168577A1 (en) | 2020-02-25 | 2021-02-25 | Gene delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516010A JP2023516010A (ja) | 2023-04-17 |
| JP2023516010A5 true JP2023516010A5 (cg-RX-API-DMAC10.html) | 2024-03-05 |
Family
ID=77490538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551783A Pending JP2023516010A (ja) | 2020-02-25 | 2021-02-25 | 遺伝子送達システム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250242012A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4110401A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023516010A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3168968A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021168577A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4117697A1 (en) * | 2020-03-13 | 2023-01-18 | PrecisionBiotics Group Limited | Bifidobacterium longum |
| JP2024511941A (ja) * | 2021-03-11 | 2024-03-18 | テンザ、インク. | 酵母における異種タンパク質の分泌を指示するための合成シグナルペプチド |
| CA3177045A1 (en) * | 2021-03-15 | 2022-09-22 | Beth Israel Deaconess Medical Center, Inc. | Compositions and methods for treating coronavirus infection |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994006903A1 (en) * | 1992-09-22 | 1994-03-31 | Dnx Biotherapeutics, Inc. | Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| AU2511901A (en) * | 1999-12-23 | 2001-07-09 | Universite De Geneve | Basolateral sorting signal and inhibitors thereof |
| US7713737B2 (en) * | 2004-10-04 | 2010-05-11 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of macromolecules |
| PT1996238T (pt) * | 2006-02-28 | 2016-07-11 | Vaxart Inc | Vetores adenovíricos quiméricos e arncd como agonista de tlr3 |
| BRPI0712073B8 (pt) * | 2006-05-17 | 2021-05-25 | Hoffmann La Roche | ácido nucléico para produção de um polipeptídio ou proteína heteróloga |
| WO2010121207A1 (en) * | 2009-04-17 | 2010-10-21 | Burnham Institute For Medical Research | Methods and compositions related to the interaction of t-cadherin and adiponectin |
| EP2985345B1 (en) * | 2013-04-10 | 2018-03-14 | National University Corporation Hamamatsu University School of Medicine | Method for inhibiting proliferation of high lix1l-expressing tumor cell, and tumor cell proliferation-inhibiting peptide |
| EP3105254B1 (en) * | 2014-02-14 | 2019-11-20 | Symvivo Corporation | Hybrid proteins and uses thereof |
| KR20170121291A (ko) * | 2015-03-02 | 2017-11-01 | 신로직 인코포레이티드 | 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아 |
| US10695385B2 (en) * | 2015-06-25 | 2020-06-30 | National University Corporation Kobe University | Oral cancer vaccine |
| EP3560513A4 (en) * | 2016-12-26 | 2020-10-14 | National University Corporation Kobe University | ANTICANCER THERAPY USING A COMBINATION OF AN ORAL TUMOR VACCINE AND AN IMMUNOSUPPRESSION INHIBITOR |
| AU2018301667A1 (en) * | 2017-07-12 | 2020-02-06 | Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Foundation | Methods and systems for conditionally regulating gene expression |
-
2021
- 2021-02-25 WO PCT/CA2021/050236 patent/WO2021168577A1/en not_active Ceased
- 2021-02-25 EP EP21760109.5A patent/EP4110401A4/en active Pending
- 2021-02-25 JP JP2022551783A patent/JP2023516010A/ja active Pending
- 2021-02-25 CA CA3168968A patent/CA3168968A1/en active Pending
- 2021-02-25 US US17/802,118 patent/US20250242012A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3030451C (en) | Compositions and methods for alphavirus vaccination | |
| Wang et al. | Oral immunization with a Lactobacillus casei‐based anti‐porcine epidemic diarrhoea virus (PEDV) vaccine expressing microfold cell‐targeting peptide Co1 fused with the COE antigen of PEDV | |
| JP2017122120A5 (cg-RX-API-DMAC10.html) | ||
| JP2020078318A5 (cg-RX-API-DMAC10.html) | ||
| CN106232138A (zh) | 新型结核分枝杆菌疫苗 | |
| CN1972710B (zh) | 包含噬菌体纳米颗粒的方法和组合物 | |
| CN106434728B (zh) | 表达高致病性禽流感h5n1血凝素ha蛋白的重组枯草芽孢杆菌 | |
| CN118086162A (zh) | 一种黏附增强型工程益生菌及其应用 | |
| US20220226459A1 (en) | Dosage regimens for vaccines | |
| Kajikawa et al. | Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1β | |
| US9925259B2 (en) | Immunogenic polypeptide surface layer-expressing bifidobacterium | |
| CN116157149A (zh) | 改造的牛分枝杆菌疫苗 | |
| CN101455846B (zh) | 脱乙酰壳聚糖递送系统组装的结核基因疫苗及其制备和应用 | |
| Yeh et al. | Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens | |
| US10226529B2 (en) | Adjuvant for mucosal vaccine | |
| JP2024523329A5 (cg-RX-API-DMAC10.html) | ||
| Lee et al. | Dendritic cell-mediated mechanisms triggered by LT-IIa-B5, a mucosal adjuvant derived from a type II heat-labile enterotoxin of Escherichia coli | |
| CN110214028A (zh) | 联合使用口服肿瘤疫苗和免疫抑制阻滞剂的癌症治疗 | |
| RU2745626C1 (ru) | Способ создания живой вакцины против коронавирусной инфекции COVID-19 на основе пробиотического штамма Enterococcus faecium L3 и живая вакцина Enterococcus faecium L3-pentF-covid-19 | |
| EP4396208A1 (en) | Tuberculosis vaccines | |
| Desheva et al. | Development of live vaccine based on the Enterococcus faecium L3 vector for prevention influenza infections | |
| KR20220113674A (ko) | 셀리악 병의 치료 | |
| CN116806146A (zh) | 呼吸系统疾病相关病症的治疗和预防 | |
| RU2782529C1 (ru) | Способ создания живого штамма энтерококка L3-SARS на основе биологически активного штамма Е. faecium L3 | |
| JP2020176221A (ja) | メンブレンヴェシクル |